Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DTC Comments Support FDA’s Goals; PhRMA Watching “Boundaries”

Executive Summary

FDA should remove language in its "disease awareness" advertising guidance suggesting the agency can take action against sponsors of "help-seeking" ads if they are the only manufacturer of a product to treat the disease, the Pharmaceutical Research & Manufacturers of America said
Advertisement

Related Content

Ads Linking “Help-Seeking” and Full Product Spots Helps Consumers – Pfizer
Ads Linking “Help-Seeking” and Full Product Spots Helps Consumers – Pfizer
FDA Disease Awareness Ad Policy Is Unfair To Small Firms, BIO Says
FDA Disease Awareness Ad Policy Is Unfair To Small Firms, BIO Says
Disease Awareness Ad Guidance Stresses Need For “Distinct” Messages
Disease Awareness Ad Guidance Stresses Need For “Distinct” Messages
Risk Information “Window” Proposed By FDA For DTC Print Ads
Advertisement
UsernamePublicRestriction

Register

PS043965

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel